Call for Abstract

Acadamia
    University of Notre Dame, USA
    University of Malta, Malta
    University of South Dakota, USA
    Centre Hospitalo-Universitaire Bichat- Claude Bernard University Diderot, France
    Medical University of Białystok, Poland
    University Medical Center Groningen, The Netherlands
    Birla Institute of Technology, India
    University of San Simón, Bolivia
    Huazhong University of Science and Technology, China
    Temple University, USA
    Sri Ramachandra University, India
    Jordan University of Science and Technology, Jordan
    Federal University of São Paulo, Brazil
    Saint Joseph’s University, USA
    Yangzhou University, China
    St. Luke’s Medical Center, Philippines
    University of Nigeria, Nigeria
    Cairo University, Egypt
    Chonbuk National University Hospital, Republic of Korea
    University of Buea, Cameroon
    University of Arkansas for Medical Sciences, USA
    Sudan International University, Sudan
    University of Nigeria, Nigeria
    Universiti Sains Islam Malaysia, Malaysia
    Universiti Teknologi MARA, Malaysia
    Tehran University of Medical Sciences, Iran
    First Moscow State Medical University, Russian Federation
    National Ribat University, Sudan
    National Ribat University, Sudan
    National University Hospital, Singapore
    Boston University School of Medicine, USA
    Advocate Illinois Masonic Medical Center, USA
    V.N Karazin National University, Ukraine
    Columbia University, USA
    Vrije Universiteit Brussel, Belgium
    Universidad Tecnológica De Santiago, USA
    Universidad Tecnológica De Santiago, Dominican Republic
    Universidad Tecnológica De Santiago, Dominican Republic
    Fudan University, China
    Tel Aviv University, Israel
    DRDC Suffield Research Center, Canada
    Yangtze University, China
    Université Catholique De Louvain, Belgium
    Université Catholique De Bukavu, Democratic Republic of Congo
    Al-Qasim Green University, Iraq
    Kuwait University, Kuwait
    University of Toronto Scarborough, Canada
    Augusta University, USA  
    Kuwait University, Kuwait
    Oakland University, USA
    Federal Fluminense University, Brazil
    Hospital D´Maria, Mexican Social Security Institute, Mexico
    El Manar University, Tunisia
    University of Texas Health Science Center at Houston, USA

     

Business
    Dutch Armed Forces / Royal Dutch Navy, Netherlands
    Decontamination Professionals International, Infection Control Technologies, USA
    Cempra Pharmaceuticals, USA
    Sanofi Pasteur, USA
    Emergency Products & Research, Inc. (EP+R), USA
    World Health Organization, Nigeria
    World Health Organization, Liberia
    Zanzibar Muslim Women Aids Support Organization (ZAMWASO), Tanzania
    Mahavir Super Specialty Hospital, India
    Dr L H Hiranandani Hospital, India
    Enugu State Ministry of Health Tuberculosis & Leprosy Unit, Nigeria
    LT USPHS, USA
    Bayer Philippines, Inc., Philippines
    Nanorx Inc, USA
    Bakhter Development Network, Afghanistan
    Grifols, USA
    The Third People’s Hospital of Wuzhou City, China
    MCH ProCare, USA 
    Stanton Territorial Health Authority, Canada

     

2nd World Congress on Infectious Diseases , will be organized around the theme “Fighting Infectious Diseases with Novel and Innovative Therapeutic Techniques ”

Infectious Diseases 2016 is comprised of 30 tracks and 202 sessions designed to offer comprehensive sessions that address current issues in Infectious Diseases 2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

The diseases caused by germs and which may infect any part of the body are called infectious diseases. They can be spread by any means where there is a germ. They are caused by pathogenic microorganisms such as bacteria, virus, parasites and fungi. Germs can be spread by direct or indirect contact. Vaccination, maintenance of proper hygiene and medicines help in the prevention of infection.

  • Track 1-1Nosocomial infections
  • Track 1-2Common infectious diseases
  • Track 1-3Communicable infectious diseases
  • Track 1-4Rare infectious diseases
  • Track 1-5Deadly infectious diseases
  • Track 1-6Infectious diseases in pregnancy
  • Track 1-7Opportunistic infections
  • Track 1-8Inflammatory infectious diseases
  • Track 1-9Tropical infectious diseases
  • Track 1-10Topical infectious diseases
  • Track 1-11Transplant infectious diseases
  • Track 1-12Neuro infectious diseases
  • Track 1-13Allergic infectious diseases
  • Track 1-14Bacterial infectious diseases
  • Track 1-15Sexually transmitted diseases
  • Track 1-16Geriatric infectious diseases
  • Track 1-17Pediatric infectious diseases
  • Track 1-18Blood borne infectious diseases
  • Track 1-19Mosquito and tick borne diseases
  • Track 1-20Water borne diseases
  • Track 1-21Food borne diseases
  • Track 1-22Air borne diseases
  • Track 1-23Mycobacterial diseases
  • Track 1-24Fungal infectious diseases
  • Track 1-25Parasitic infectious diseases
  • Track 1-26Viral infectious diseases

Infectious diseases can be caused by bacteria, virus, fungi and parasites through direct contact, indirect contact, insect bites and food contamination. Each infectious disease has its own specific signs and symptoms. General signs and symptoms common to a number of infectious diseases include fever, diarrhoea, fatigue and muscle aches.

An Infectious disease whose occurrence has increased in the past years or threatens to increase is termed as emerging. These diseases include new infections, previously unrecognized infections and old infections reappearing due to antimicrobial resistance, public health issues and unhygienic conditions.

  • Track 3-1Inflammatory drug development
  • Track 3-2NSAIDS drug development
  • Track 3-3Evolutionary biology
  • Track 3-4Modelling of infectious diseases
  • Track 3-5Vaccination
  • Track 3-6Seasonal vaccines
  • Track 3-7H1N1 vaccines
  • Track 3-8Chemotherapy

Clinical studies helps in inventing new treatment methods which helps in providing effective treatment. Case reports on infectious diseases include research, biology, epidemiology and clinical aspects of all infection related diseases.

  • Track 4-1MERS-COV case reports
  • Track 4-2Zika viral infections outbreak
  • Track 4-3Ebola viral infections outbreak
  • Track 4-4HIV-AIDS clinical studies and case reports
  • Track 4-5Mycobacterial diseases case reports
  • Track 4-6Hepatitis case reports
  • Track 4-7Malarial infections clinical studies and case reports
  • Track 4-8Sepsis

Microbial pathogenesis is the study of the molecular mechanisms used by microorganisms to cause disease in humans and animals. By understanding how pathogens cause disease helps in the development of new therapeutic approaches. Virulence is the measure of the pathogenicity of an organism. The degree of virulence is related directly to the ability of the organism to cause infection despite host resistance mechanisms, it is affected by numerous variables such as the number of infecting bacteria, route of entry into the body, specific and nonspecific host defence mechanisms and virulence factors of the bacterium.

  • Track 5-1Microbiota
  • Track 5-2Systems biology
  • Track 5-3Vaccine design
  • Track 5-4Mechanisms of microbial pathogenesis
  • Track 5-5Virulence factors
  • Track 5-6Immune mechanisms
  • Track 5-7Host pathogen interactions
  • Track 5-8Host cell interactions
  • Track 5-9Host response
  • Track 5-10Host susceptibility or host resistance
  • Track 5-11Molecular biology
  • Track 5-12Molecular analysis
  • Track 5-13Genomic approaches
  • Track 5-14Genetic studies
  • Track 5-15Drug interactions
  • Track 5-16Identification, cloning and sequencing of relevant genes

Immunology of infections means the battle between pathogens and the host immune defences. Immunology is the branch of science concerned with the various aspects related to immune system, innate and acquired immunity. Immunology also deals with laboratory techniques involving the interaction of antigens with specific antibodies.

  • Track 6-1Pathogens and the immune system: spread, persistence and transmission
  • Track 6-2Vaccine development
  • Track 6-3Response of macrophages, dendritic cells to bacterial and mycobacterial infection
  • Track 6-4Host immune response
  • Track 6-5Innate immune evasion
  • Track 6-6Immuno epidemiology
  • Track 6-7Immune system regulatory control
  • Track 6-8Innate recognition
  • Track 6-9Membrane dynamics
  • Track 6-10Host interactions and system biology
  • Track 6-11Immunology of diseases

Mechanism of resistance towards antimicrobials by microorganisms includes the following mechanisms of enzymatic destruction, enzymatic modification, altered target and decreased uptake. Mechanism of resistance is due to the inactivation or modification of antibiotics, an alteration in the target site of the antibiotic that reduces its binding capacity, the modification of metabolic pathways to circumvent the antibiotic effect and the reduced intracellular antibiotic accumulation by decreasing permeability and/ or increasing active efflux of the antibiotic.

  • Track 7-1Multi drug resistance
  • Track 7-2Antimicrobial resistance
  • Track 7-3Antibiotic resistance
  • Track 7-4Malarial drug resistance
  • Track 7-5Multidrug resistant tuberculosis
  • Track 7-6Drug resistant tuberculosis
  • Track 7-7Development and spread of resistance to anti bacterial, anti fungal, anti parasitic, anti mycobacterial and anti viral agents
  • Track 7-8Antiviral drug resistance
  • Track 7-9Genetic modification
  • Track 7-10Animal pathogens, vaccines and functional genomics
  • Track 7-11Methicillin resistant staphylococcus aureus
  • Track 7-12Vancomycin resistant enterococci
  • Track 7-13Multidrug resistant pseudomonas aeruginosa and clostridium difficile
  • Track 7-14Extended spectrum beta lactamase producing enterobacteriaceae
  • Track 7-15Carbapenemase producing enterobacteriaceae

Antimicrobial/ antibiotic/ antibacterial resistance is the ability of microorganisms to resist the effects of drugs that means diseases causing germs do not get killed and their growth is not stopped.  Antibiotic resistant infections are of greater risk which cannot be avoided completely. Infections with resistant organisms are difficult to treat requiring costly and sometimes toxic alternatives.

Antimicrobial/ antibiotic/ antibacterial stewardship promotes the appropriate use of antimicrobials which improves patient outcomes reduces microbial resistance and decreases the spread of infections caused by multidrug resistant organisms.

Epidemiology studies the patterns, causes and effects of health and disease conditions. It is the cornerstone of public health and informs policy decisions and evidence based practice by identifying risk factors for disease and targets for preventive healthcare. Epidemiologists help with study design, data collection, statistical analysis of data, interpretation and dissemination. Epidemiology helped to develop methodology used in clinical research, public health studies and to a lesser extent basic research in the biological sciences.

  • Track 10-1Study design, collection, statistical analysis of data, interpretation and dissemination
  • Track 10-2Modes of transmission and interventions
  • Track 10-3Patterns, causes and effects
  • Track 10-4Risk factors
  • Track 10-5Methodology
  • Track 10-6Public health studies
  • Track 10-7Research in biological sciences
  • Track 10-8Immuno pathogenesis
  • Track 10-9Molecular insights and genomic studies
  • Track 10-10Vaccine development
  • Track 10-11Concepts and techniques of disease prevention

Medical diagnosis is the process of determining which disease or condition explains a person's symptoms and signs. Laboratory tests may identify organisms directly (e.g., visually, using a microscope growing the organism in culture) or indirectly (e.g., identifying antibodies to the organism). General types of tests include microscopy, culture and immunologic tests (agglutination tests such as latex agglutination, enzyme immunoassays, western blot, precipitation tests and complement fixation tests) and nucleic acid/ non nucleic acid based identification methods. Sub types of diagnoses include clinical, laboratory, radiology, principal and admitting diagnosis. Advanced methods have been implemented to diagnose the infection in any part of the body. Examples include biomarkers/ elisa test/ chest x ray/ skin biopsy/ tympanometry and tympanocentesis.

  • Track 11-1Antigen and antibody assay
  • Track 11-2Vaccine vectors
  • Track 11-3Microscopy and culture
  • Track 11-4Clinical tests
  • Track 11-5Laboratory tests
  • Track 11-6Serological tests
  • Track 11-7Immunological tests
  • Track 11-8Nucleic acid and non nucleic acid based identification methods
  • Track 11-9Radiology
  • Track 11-10Biomarkers
  • Track 11-11Elisa test
  • Track 11-12Chest x ray
  • Track 11-13Tympanometry
  • Track 11-14Tympanocentesis
  • Track 11-15Novel diagnostics

Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Yeast infections can be primarily treated by sterilisation methods. Parasitic infections can be treated by antiparasitic drugs. Diseases such as cancer can be treated by chemotherapy. Recent techniques have proved that there is no disease that cannot be treated.

  • Track 12-1Biothreat agents
  • Track 12-2Antimalarials
  • Track 12-3Antituberculars
  • Track 12-4Antimycobacterials
  • Track 12-5Antiparasitics
  • Track 12-6Antifungals
  • Track 12-7Antiretrovirals
  • Track 12-8Antivirals
  • Track 12-9Antibacterials
  • Track 12-10Antimicrobials
  • Track 12-11Antibiotics
  • Track 12-12Antiseptics
  • Track 12-13Biopharmaceutical products
  • Track 12-14Interventional agents
  • Track 12-15Disinfectants
  • Track 12-16Herbal treatment
  • Track 12-17Traditional medicines
  • Track 12-18Chemotherapy
  • Track 12-19Vaccines and vaccination
  • Track 12-20Antiinflammatory drugs and NSAIDS
  • Track 12-21Anticancers

Infectious diseases prevention and control is helpful to prevent the transmission of infectious diseases. Aseptic technique is normally applied to prevent the infections caused by different means. Sterilization is another process of killing microorganisms by the application of heat. Disinfection is the process of killing harmful microorganisms. Some infectious diseases can be prevented by avoiding direct contact with the contagious person. Infections can also be controlled and prevented by creating public awareness on various infectious diseases and their outbreaks. Infections can be cured by various antimicrobials.

  • Track 13-1Global health
  • Track 13-2Vaccines
  • Track 13-3Alternative therapies
  • Track 13-4Detection of molecular targets for drug development
  • Track 13-5Good hygienic practices
  • Track 13-6Infection control
  • Track 13-7Infectious diseases diagnosis
  • Track 13-8Infectious diseases treatment and cure
  • Track 13-9Public awareness about emerging infectious diseases
  • Track 13-10Awareness of STD
  • Track 13-11Medication
  • Track 13-12Infection prevention

Infectious diseases vaccines are the vaccines which prevent the infectious diseases and infectious diseases like diphtheria, haemophilus influenzae serotype b infection, hepatitis b, measles, meningitis, mumps, pertussis, poliomyelitis, rubella, tetanus, tuberculosis and yellow fever are preventable through vaccines.

Sexually transmitted diseases/ sexually transmitted infections are the infections which are transmitted through sexual contact with an infected individual and also transmitted during vaginal or other types of sexual intercourse including oral and anal sex.

Pediatric infectious diseases/ childhood infectious diseases are the infectious diseases which are caused in children of different age groups. Pediatric infectious diseases specialist’s takes care of the infections occurring in children and the treatment methods vary for children from adults.

Neuro infectious diseases are the infectious diseases which are observed in the nervous system. Viral and immune mediated disorders of the nervous system are among the most challenging neurological disorders. The most common neuro immune disorder is multiple sclerosis and hiv is the most common viral infection of the nervous system.

Nosocomial infections/ hospital acquired infections/ health care associated infections are the infections that are contracted from the environment or staff of a healthcare facility and they spread in the hospital environment, nursing home environment, rehabilitation facility and clinic or other clinical settings.

Blood stream infections/ bacteraemia/ septicaemia/ blood poisoning occurs when a bacterial infection elsewhere in the body such as in the lungs or skin which enters the blood stream. This is dangerous because the bacteria and their toxins can be carried through the blood stream to the entire body.

Urinary tract infections are the infections which are observed in any part of the urinary system (kidneys, ureters, bladder and urethra). Mostly infections are observed in the lower urinary tract (bladder and urethra). Women are at greater risk than men.

Surgical site infections are the infections which may occur within 30 days after the operation and are observed in the parts of skin and subcutaneous tissue of the incision.

Ebola virus disease is caused by virus transmitted through body fluids and through air. It occurs rarely but it is very deadly which results in death and outbreak. Ebola virus disease symptoms are very severe which appears in 2-3 days. Ebola primary symptoms include fever, sore throat, muscular pain and headaches then followed by vomiting, diarrhea, rash, decreased function of the liver and kidneys then loss of blood internally and externally finally leading to low blood pressure and fluid loss resulting in death.

  • Track 22-1Outbreaks
  • Track 22-2Epidemiology of ebola
  • Track 22-3Symptoms and pathophysiology
  • Track 22-4Diagnosis
  • Track 22-5Molecular genetics and current research
  • Track 22-6Prevention, control and cure
  • Track 22-7Therapeutic measures and vaccination
  • Track 22-8Health care
  • Track 22-9Public awareness

Tuberculosis is a bacterial infection caused by a bacterium called mycobacterium tuberculosis which spread through the lymph nodes and blood stream to any organ in your body. It is most commonly found in the lungs which attack the lungs and it can also attack any part of the body such as the kidney, spine and brain.

  • Track 23-1Rapid sputum tests for tuberculosis
  • Track 23-2Multidrug resistant tuberculosis
  • Track 23-3Drug resistant tuberculosis
  • Track 23-4Tuberculosis in children
  • Track 23-5TB and HIV coinfection
  • Track 23-6Tuberculosis in people with HIV

Hepatitis is caused by the inflammation of the liver and characterized by the presence of inflammatory cells in the tissue of the organ. Hepatitis may occur with limited or no symptoms but often leads to jaundice, poor appetite and malaise. Hepatitis is acute when it lasts less than six months and chronic when it persists longer.

  • Track 24-1Hepatic cirrhosis
  • Track 24-2Liver disorders
  • Track 24-3Prognosis
  • Track 24-4Giant cell hepatitis
  • Track 24-5Ischemic hepatitis
  • Track 24-6Non alcoholic fatty liver disease
  • Track 24-7Auto immune hepatitis
  • Track 24-8Toxic and drug induced hepatitis
  • Track 24-9Alcoholic hepatitis
  • Track 24-10Hepatitis A
  • Track 24-11Viral hepatitis
  • Track 24-12Chronic hepatitis
  • Track 24-13Acute hepatitis
  • Track 24-14Hepatitis E
  • Track 24-15Hepatitis D
  • Track 24-16Hepatitis C
  • Track 24-17Hepatitis B

Malaria is a mosquito borne infectious disease affecting humans and other animals caused by parasitic protozoans (a group of single celled microorganisms) belonging to the plasmodium type. Malaria symptoms typically include fever, fatigue, vomiting and headaches which can be observed in 10-15 after being bitten by mosquito. In severe cases it can cause yellow skin, seizures, comaor and even death.

Microbial forensics and molecular basis of bacteria is defined as a scientific discipline which is used to analyse microorganism/ toxin release.

  • Track 26-1Epidemiology
  • Track 26-2Bioinformatics, genetics and case studies
  • Track 26-3Bioterrorism agents
  • Track 26-4Lineage based approach

Animal infectious diseases/ zoonosis are important threat to human health since the emergence of human diseases is dominated by zoonotic pathogens. Infectious diseases affect livestock and also wild animals focusing on characterizing the conditions for the pathogen spread and maintenance in the host population.

  • Track 27-1African swine fever
  • Track 27-2Rabies
  • Track 27-3Diseases causing microbes in animals
  • Track 27-4Parasitic diseases in animals
  • Track 27-5Clostridial diseases
  • Track 27-6Transmission of infections by animals

Plant pathology is the study of diseases in plants caused by pathogens and environmental conditions. Organisms that cause infectious diseases include fungi, oomycetes, bacteria, viruses, viroids, virus like organisms, phytoplasmas, protozoa, nematodes and parasitic plants. Plant pathology also involves the study of pathogen identification, disease etiology, disease cycles, economic impact, plant disease epidemiology, plant disease resistance, how plant diseases affect humans and animals, pathosystem genetics and management of plant diseases.

  • Track 28-1Epidemiology
  • Track 28-2Biological control agents
  • Track 28-3Modelling of infectious diseases in plants
  • Track 28-4Phytopathology
  • Track 28-5Pathogen survival and dispersal of plant parasites

Global market report of infectious diseases is a complete study of current trends in the infectious diseases therapeutic and diagnostic market, industry growth drivers, advanced therapies and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology for infection diagnosis and treatment. Market reports also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

  • Track 29-1Drug formulation devices
  • Track 29-2Chemicals and bulk drugs
  • Track 29-3Laboratory testing tools
  • Track 29-4Drug device combinations
  • Track 29-5Filter media
  • Track 29-6Devices and instruments
  • Track 29-7Environmental products
  • Track 29-8Pharmaceuticals
  • Track 29-9Nano materials
  • Track 29-10Testing tools
  • Track 29-11Molecular diagnostics
  • Track 29-12Municipal water treatment

Entrepreneurs from infectious diseases field can exhibit their products and can give presentations on their products which should be helpful in research work, business development and marketing.